Cargando…

Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3)

Although cancer cells need more glucose than normal cells to maintain energy demand, chronic hyperglycemia induces metabolic alteration that may dysregulate signaling pathways, including the O-GlcNAcylation and HIF1A (Hypoxia-inducible factor 1-alpha) pathways. Metformin was demonstrated to evoke me...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogalska, Aneta, Forma, Ewa, Bryś, Magdalena, Śliwińska, Agnieszka, Marczak, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163973/
https://www.ncbi.nlm.nih.gov/pubmed/30217067
http://dx.doi.org/10.3390/ijms19092750
_version_ 1783359489495269376
author Rogalska, Aneta
Forma, Ewa
Bryś, Magdalena
Śliwińska, Agnieszka
Marczak, Agnieszka
author_facet Rogalska, Aneta
Forma, Ewa
Bryś, Magdalena
Śliwińska, Agnieszka
Marczak, Agnieszka
author_sort Rogalska, Aneta
collection PubMed
description Although cancer cells need more glucose than normal cells to maintain energy demand, chronic hyperglycemia induces metabolic alteration that may dysregulate signaling pathways, including the O-GlcNAcylation and HIF1A (Hypoxia-inducible factor 1-alpha) pathways. Metformin was demonstrated to evoke metabolic stress and induce cancer cell death. The aim of this study was to determine the cytotoxic efficiency of metformin on SKOV-3 cells cultured in hyperglycemia and normoglycemia. To identify the potential mechanism, we assessed the expression of O-linked β-N-acetlyglucosamine transferase (OGT) and glycoside hydrolase O-GlcNAcase (OGA), as well as hypoxia-inducible factor 1-alpha (HIF1A) and glucose transporters (GLUT1, GLUT3). SKOV-3 cells were cultured in normoglycaemia (NG, 5 mM) and hyperglycemia (HG, 25 mM) with and without 10 mM metformin for 24, 48, and 72 h. The proliferation rate, apoptotic and necrotic SKOV-3 cell death were evaluated. Real-Time qPCR was employed to determine mRNA expression of OGT, OGA, GLUT1, GLUT3, and HIF1A. Metformin significantly reduced the proliferation of SKOV-3 cells under normal glucose conditions. Whereas, the efficacy of metformin to induce SKOV-3 cell death was reduced in hyperglycemia. Both hyperglycemia and metformin induced changes in the expression of genes involved in the O-GlcNAcylation status and HIF1A pathway. The obtained results suggest that dysregulation of O-GlcNAcylation, and the related HIF1A pathway, via hyperglycemia, is responsible for the decreased cytotoxic efficiency of metformin in human ovarian cancer cells.
format Online
Article
Text
id pubmed-6163973
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61639732018-10-10 Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3) Rogalska, Aneta Forma, Ewa Bryś, Magdalena Śliwińska, Agnieszka Marczak, Agnieszka Int J Mol Sci Article Although cancer cells need more glucose than normal cells to maintain energy demand, chronic hyperglycemia induces metabolic alteration that may dysregulate signaling pathways, including the O-GlcNAcylation and HIF1A (Hypoxia-inducible factor 1-alpha) pathways. Metformin was demonstrated to evoke metabolic stress and induce cancer cell death. The aim of this study was to determine the cytotoxic efficiency of metformin on SKOV-3 cells cultured in hyperglycemia and normoglycemia. To identify the potential mechanism, we assessed the expression of O-linked β-N-acetlyglucosamine transferase (OGT) and glycoside hydrolase O-GlcNAcase (OGA), as well as hypoxia-inducible factor 1-alpha (HIF1A) and glucose transporters (GLUT1, GLUT3). SKOV-3 cells were cultured in normoglycaemia (NG, 5 mM) and hyperglycemia (HG, 25 mM) with and without 10 mM metformin for 24, 48, and 72 h. The proliferation rate, apoptotic and necrotic SKOV-3 cell death were evaluated. Real-Time qPCR was employed to determine mRNA expression of OGT, OGA, GLUT1, GLUT3, and HIF1A. Metformin significantly reduced the proliferation of SKOV-3 cells under normal glucose conditions. Whereas, the efficacy of metformin to induce SKOV-3 cell death was reduced in hyperglycemia. Both hyperglycemia and metformin induced changes in the expression of genes involved in the O-GlcNAcylation status and HIF1A pathway. The obtained results suggest that dysregulation of O-GlcNAcylation, and the related HIF1A pathway, via hyperglycemia, is responsible for the decreased cytotoxic efficiency of metformin in human ovarian cancer cells. MDPI 2018-09-13 /pmc/articles/PMC6163973/ /pubmed/30217067 http://dx.doi.org/10.3390/ijms19092750 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rogalska, Aneta
Forma, Ewa
Bryś, Magdalena
Śliwińska, Agnieszka
Marczak, Agnieszka
Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3)
title Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3)
title_full Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3)
title_fullStr Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3)
title_full_unstemmed Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3)
title_short Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3)
title_sort hyperglycemia-associated dysregulation of o-glcnacylation and hif1a reduces anticancer action of metformin in ovarian cancer cells (skov-3)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163973/
https://www.ncbi.nlm.nih.gov/pubmed/30217067
http://dx.doi.org/10.3390/ijms19092750
work_keys_str_mv AT rogalskaaneta hyperglycemiaassociateddysregulationofoglcnacylationandhif1areducesanticanceractionofmetformininovariancancercellsskov3
AT formaewa hyperglycemiaassociateddysregulationofoglcnacylationandhif1areducesanticanceractionofmetformininovariancancercellsskov3
AT brysmagdalena hyperglycemiaassociateddysregulationofoglcnacylationandhif1areducesanticanceractionofmetformininovariancancercellsskov3
AT sliwinskaagnieszka hyperglycemiaassociateddysregulationofoglcnacylationandhif1areducesanticanceractionofmetformininovariancancercellsskov3
AT marczakagnieszka hyperglycemiaassociateddysregulationofoglcnacylationandhif1areducesanticanceractionofmetformininovariancancercellsskov3